Recent Quotes (30 days)

You have no recent quotes
chg | %

Formation Group plc news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

FRM 1.87 -0.05 (-2.86%)
price chart
Formation Group PLC Acquisition of development site in London
Formation Group PLC (AIM: FRM) is pleased to announce that, through a wholly owned subsidiary Formation Homes (London) Limited, it has exchanged on the purchase of a development site at 159-161 Iverson Road, London for the consideration of ...
Formation Group announces London development purchase  Stock Market Wire
Formation Subsidiary To Acquire Development Site In North West London  London South East
Related articles »  
Formation Group Sells Off 7.5% Stake To Related Party
LONDON (Alliance News) - Formation Group PLC said Thursday it has sold 16,497,258 treasury shares, approximately 7.48% of its issued share capital, to related party, Kennedy Private Trust Company.
Thomas Cook Group plc: TCG Near-Term Outlook Brightens as Host of ...
Thomas Cook Group plc (LON:TCG) shares are trading 1.18 pct up on last night's closing rate having achieved the level of 180.3.
Related articles »  
Bank Cutting Commodities Trade Severs Link With Equities
As Barclays Plc, JPMorgan Chase & Co. and Morgan Stanley leave parts of the business, prices of commodities are moving more independently of stocks.
Related articles »  
Maliki Looks to Iraq's Oil Gusher for Election Edge Amid Strife
Under Maliki's leadership, Iraq, with the world's fifth-largest oil reserves, overtook Iran as the second-biggest producer in the Organization of Petroleum Exporting Countries, helped by foreign investors including Royal Dutch Shell Plc (RDSA) and ...
Related articles »  
Oil & Gas Roundup
... encountered in the Esmeraldas formation at Fenix Post period end highlights:� Platanillo-17 became the 12th successful well in the current campaign� New Vertical Seismic Profile Data acquired during drilling programme strengthened Platanillo field ...
Related articles »  
Why Allergan may have to give in to Valeant and Bill Ackman's US$47-billion bid
With its key product Botox, a nerve-inhibiting injection which minimizes the look and formation of wrinkles, as well as its other dermatological and eyecare products, Allergan is an ideal fit for the acquisitive Valeant and its own product portfolio ...
Flurry of deals reshapes pharma industry
The deals, which include Novartis' purchase of GSK's cancer drugs and GSK's acquisition of Novartis' vaccines business, came just after a newspaper report that AstraZeneca Plc had turned down a $US101 billion bid approach from Pfizer Inc, a story that ...
Novartis And GlaxoSmithKline Trade $20 Billion In Assets Amid Changing ...  International Business Times
Related articles »  
Novartis and GSK trade assets as pharma industry reshapes
The deals, which include Novartis' purchase of GSK's cancer drugs and GSK's acquisition of Novartis' vaccines business, came just after a newspaper report that AstraZeneca Plc had turned down a $101 billion bid approach from Pfizer Inc, a story that ...
Valeant's $44.4B bid to buy Botox maker Allergan would mark biggest takeover ...
The proposed acquisition by Laval, Quebec-based Valeant would surpass Vivendi SA's US$43.9 billion purchase of spirits maker Seagram Co.
Related articles »